| Literature DB >> 23559597 |
Cuiping Chi1, Rong Tian, Huifang Liu, Haiyan Wang, Jinping Wei, Jianping Guo, Fengling Guo, Shufang Li.
Abstract
In order to identify biomarkers for early diagnosis and/or for therapeutic targets in the delayed health effects of ionizing radiation, we analyzed the subgroups of lymphocytes, serum protein levels and gene expression profiles in the peripheral blood of three ⁶⁰Co γ-ray accidentally exposed persons during the three years after irradiation. Flow cytometry analyses and agarose gel electrophoresis were applied to investigate the subgroups of lymphocytes and the composition of serum proteins, respectively. Gene expression profiling was obtained using a whole genome gene expression chip assay. Both the percentage of CD4+ T lymphocytes and the ratio of Th to Ts were reduced compared with the normal control values. The percentage of albumin decreased whereas beta globulin increased. There were 285 up-regulated and 446 down-regulated genes in irradiated samples relative to the control samples. The expression of KDR, CEACAM8 and OSM was validated by RT-PCR. The majority of the differentially expressed genes encode proteins associated with the immune response, inflammation, oncogenesis, cell structure, oxidative stress, neuro-hormone regulation, reproduction, susceptibility to psychiatric disorders, or transcriptional regulation. We have identified a number of promising novel candidates that have potential for serving as biomarkers for delayed damage. Furthermore, the changes in the immunological indicator CD4+ T cells, and the ratio of CD4+ T to CD8+ T cells may be biomarkers for the prediction of delayed damage by ionizing radiation. The findings of our study are useful for forming a comprehensive understanding of the mechanisms underlying the delayed effects of ionizing radiation.Entities:
Keywords: accidental exposure; gene expression profile; radiation biomarkers; ratio of Th to Ts
Mesh:
Substances:
Year: 2013 PMID: 23559597 PMCID: PMC3766294 DOI: 10.1093/jrr/rrt022
Source DB: PubMed Journal: J Radiat Res ISSN: 0449-3060 Impact factor: 2.724
Fig. 1.Overview of experimental design.
Primers for genes of KDR, OSM, CEACAM8 and ACTB
| Gene | Sequence | Length of product (bp) |
|---|---|---|
| KDR | forward: 5'CTCAAACCAGACAAGCGGCTA3′ | 121 |
| backward: 5'GCTACCGGTTTGCACTCCAAT3′ | ||
| OSM | forward: 5'CCAGACTTCCTCCTTTCCGTG3′ | 137 |
| backward: 5'ACACCCTGCCGCTGTTACAG3′ | ||
| CEACAM8 | forward: 5'TCAGTGACCCAGTCACCCTGA3′ | 122 |
| backward: 5'TGGATTAGAGGCCGCATGG3′ | ||
| ACTB | forward: 5'AAGTACTCCGTGTGGATCGGC3′ | 125 |
| backward: 5'GCCTAGAAGCATTTGCGGTG3′ |
Leukocytes and lymphocyte percentage in the peripheral blood of accidentally exposed persons
| Cell type | Time after radiation | A | B | C | Reference value |
|---|---|---|---|---|---|
| (11.2 Gy) | (1.82 Gy) | (1.0 Gy) | |||
| Leukocyte (×109/l) | 2 h | 9.89 | 7.97 | 10.4 ↑ | 4–10 109/l |
| 4 h | 12.75 ↑ | 12.09 ↑ | 15.86 ↑ | ||
| 1 year | 5.73 | 4.61 | 5.01 | ||
| 2 year | 7.19 | 4.4 | 5.52 | ||
| 3 year | 5.46 | 4.67 | 5.57 | ||
| Lymphocyte (%) | 2 h | 8.92 ↓ | 14.62 ↓ | 12.82 ↓ | 20–40% |
| 4 h | 3.52 ↓ | 4.82 ↓ | 4.62 ↓ | ||
| 1 year | 18.02 ↓ | 25.8 | 25.7 | ||
| 2 year | 16.02 ↓ | 27 | 24.5 |
Lymphocyte sub-groups distribution (%) in the accidentally exposed persons
| Cell classification | Time after irradiation (year) | A (11.2 Gy) | B (1.82 Gy) | C (1.0 Gy) | Reference value (%) |
|---|---|---|---|---|---|
| Th (CD3 + CD4 + ) | 1 | 18.7 ↓ | 25.9 ↓ | 26.7 ↓ | 30.09–40.41 |
| 2 | 19.0 ↓ | 27.1 ↓ | 28.0 ↓ | ||
| 3 | 19.5 ↓ | 28.2 ↓ | 27.2 ↓ | ||
| Ts (CD3 + CD8 + ) | 1 | 41.7 ↑ | 27.8 | 29.6 | 20.74–29.42 |
| 2 | 34.6 ↑ | 25.5 | 30.9 ↑ | ||
| 3 | 35.9 ↑ | 24.3 | 29.3 | ||
| Th/Ts | 1 | 0.45 ↓ | 0.93 ↓ | 0.90 ↓ | 0.98–1.94 |
| 2 | 0.55 ↓ | 1.06 | 0.91 ↓ | ||
| 3 | 0.54 ↓ | 1.16 | 0.93 ↓ | ||
| Total T cell (CD3+) | 1 | 62.1 | 57.6 ↓ | 59.9 ↓ | 60.0–80.0 |
| 2 | 56.1 ↓ | 56.4 ↓ | 61.8 | ||
| 3 | 56.6 ↓ | 56.0 ↓ | 60.1 | ||
| NK cell {CD3–CD(16 + 56) + } | 1 | 5.50 ↓ | 24.5 | 27.8 ↑ | 8.1–25.6 |
| 2 | 5.0 ↓ | 28.3 ↑ | 22.2 | ||
| 3 | 5.3 ↓ | 23.6 | 17.2 | ||
| CD3 + CD(16 + 56) + | 1 | 0.30 | 0.10 | 0.30 | <5 |
| 2 | 8.6 ↑ | 5.4 ↑ | 3.4 | ||
| 3 | 4.8 | 3.0 | 1.4 | ||
| CD19 + | 1 | 24.6 ↑ | 9.40 | 13.9 | 9–15 |
| 2 | 38.1 ↑ | 14.8 | 15.1 | ||
| 3 | 34.5 ↑ | 16.6 ↑ | 11.5 |
Serum proteins distribution (%) in the three accidentally exposed persons
| Component | Time after irradiation (year) | A (11.2 Gy) | B (1.82 Gy) | C (1.0 Gy) | Reference value (%) |
|---|---|---|---|---|---|
| Albumin | 1 | 58.65 | 46.89↓ | 62.74 | 52.30–66.00 |
| 2 | 42.75↓ | 50.89↓ | 42.26↓ | ||
| 3 | 49.49↓ | 45.59↓ | 49.25↓ | ||
| Alpha 1 | 1 | 3.45 | 6.43 | 2.97↓ | 3.30–7.00 |
| 2 | 5.06 | 2.55↓ | 4.36 | ||
| 3 | 5.99 | 4.41 | 2.55↓ | ||
| Alpha2 | 1 | 7.59 | 7.23 | 4.96↓ | 6.30–11.70 |
| 2 | 15.71↑ | 8.78 | 10.79 | ||
| 3 | 10.42 | 6.83 | 9.19 | ||
| Beta | 1 | 16.04↑ | 12.58 | 12.81 | 7.80–14.00 |
| 2 | 18.26↑ | 14.83↑ | 16.44↑ | ||
| 3 | 17.37↑ | 16.27↑ | 17.06↑ | ||
| Gamma | 1 | 14.27 | 26.87↑ | 16.72 | 11.10–20.40 |
| 2 | 18.21 | 22.96 | 26.16↑ | ||
| 3 | 16.73 | 26.90↑ | 21.49↑ | ||
| Ratio | 1 | 1.42 | 0.88 | 1.68 | |
| 2 | 0.75 | 1.04 | 0.73 | ||
| 3 | 0.98 | 0.84 | 0.97 |
Partial list of upregulated genes
| Accession number | Gene | Protein | Log2Ratio |
|---|---|---|---|
| NM_018702 | ADARB2 | adenosine deaminase B2 | 6 |
| NM_001925 | DEFA4 | defensin, alpha 4 | 3 |
| NM_006671 | SLC1A7 | solute carrier family 1 (glutamate transporter), member 7 | 3.5 |
| NM_004171 | SLC1A2 | solute carrier family 1, member 2 | 2.7 |
| NM_000853 | GSTT1 | glutathione S-transferase theta 1 | 4.7 |
| NM_002424 | MMP8 | matrix metallopeptidase 8 | 3.9 |
| NM_005143 | HP | haptoglobin | 4.3 |
| NM_020995 | HPR | haptoglobin-related protein | 4.0 |
| NM_005980 | S100P | S100 calcium binding protein P | 3.7 |
| NM_001972 | ELANE | elastase | 2.5 |
| NM_000494 | COL17A1 | collagen, type XVII, alpha 1 | 3.0 |
| NM_004496 | FOXA1 | forkhead box A1 | 3.9 |
| NM_015714 | GOS2 | G0/G1switch 2 | 3.7 |
| NM_004430 | EGR3 | early growth response 3 | 3.0 |
| NM_000963 | PTGS2 | inducible cyclooxygenase | 2.5 |
| NM_001549 | IFIT3 | interferon-induced protein with tetra-tricopeptide repeats 3 | 2.0 |
Partial list of immunological function-associated genes
| Accession number | Gene | Protein | Log2Ratio |
|---|---|---|---|
| NM_000588 | IL3 | interleukin 3 | –3.7 ↓ |
| BC040272 | IL16 | interleukin 16 | –2.9 ↓ |
| NM_002253 | KDR | kinase insert domain receptor | –3.5 ↓ |
| NM_002175 | IFNA21 | interferon, alpha 21 | –2.5 ↓ |
| NM_030788 | TM7SF4 | transmembrane 7 superfamily member 4 | +2.5 ↑ |
| NM_020530 | OSM | oncostatin M | +2.6 ↑ |
| NM_001816 | CEACAM8 | carcinoembryonic antigen-related cell adhesion molecule 8 | +2.5 ↑ |
| NM_002343 | LTF | lactotransferrin | +2.5 ↑ |
| NM_000547 | TPO | thyroid peroxidase | +2.8 ↑ |
| NM_080657 | RSAD2 | radical S-adenosyl methionine domain containing 2 | +2.6 ↑ |
Partial list of down-regulated genes
| Accession number | Gene | Protein | Log2Ratio |
|---|---|---|---|
| NM_198129 | LAMA3 | laminin, alpha 3 | –4.3 |
| NM_001464 | ADAM2 | ADAM metallopeptidase domain 2 | –4.7 |
| NM_001079858 | GPR64 | G protein-coupled receptor 64 | –4.6 |
| NM_194250 | ZNF804A | zinc finger protein 804A | –4.1 |
| NM_145740 | GSTA1 | glutathione S-transferase alpha 1 | –4.0 |
| NM_016931 | NOX4 | NADPH oxidase 4 | –4.3 |
| NM_001137669 | RGSL1 | regulator of G-protein signaling like 1 | –4.1 |
| NM_005438 | FOSL1 | FOS-like antigen 1 | –3.4 |
| NM_020868 | DPP10 | dipeptidyl peptidase 10 | –3.9 |
| NM_000817 | GAD1 | glutamate decarboxylase 1 | –3.4 |
| NM_153699 | GSTA5 | glutathione S-transferase alpha 5 | –3.9 |
| NM_004883 | NRG2 | neuregulin2 | –3.4 |
| NM_003551 | NME5 | non-metastatic cells 5 | –3.2 |
| NM_001836 | CMA1 | chymase 1 | –3.4 |
| NM_001040105 | MUC17 | mucin17 | –3.4 |
| NM_080801 | COL13A1 | collagen, type XIII, alpha 1 | –3.0 |
| NM_002538 | OCLN | occludin | –3.4 |
Fig. 2.Differentially expressed genes, related pathological processes and delayed effects of ionizing radiation. The diseases (late effects) in the shaded rectangles indicate the diseases already occurring in the exposed individuals, while the diseases noted in black ellipses are as yet non-occurring. Solid arrows show the results of gene expressions, and dotted arrows connect the pathological processes indicated by the results of gene expressions to the delayed effects (diseases).